Vertiv (VRT) Deep Research — Bilingual Edition
3rd edition · EN + ZH PDFs · 19 figures, 31 tables · three-horizon view · Target-price analysis
- Type
- Company
- Series
- VRT
- Data as of
- 2026-08-27
- Pages
- 44
- Format
- Category
- Research Reports
- Delivery
- File download delivery
- Publisher
- TopxAI Research
- Listing updated
- 2026-08-24
Sample
8 of 44 pagesDescription
Vertiv Holdings Co (NYSE: VRT) company deep dive, third edition. Two PDFs — Chinese (40 pp) and English (43 pp) — each with 19 chapters plus 4 appendices, 19 charts and 31 data tables, figure-for-figure identical across the two editions; every derived number is walked step by step in Appendix D. Reference date: close of 27 August 2026.
Five core judgements
| # | Judgement | Key numbers |
|---|---|---|
| 1 | The order-disclosure halt was an announced policy change; the cost is an unanchored share price — this edition holds the call transcripts, the peer comparison and three earnings-day price reactions | +24.5% on announcement day; the first un-anchored revenue miss cleared −17.3% in one session (NDX −2.0%) |
| 2 | Growth no longer consumes shareholder capital: customers and suppliers fund the expansion | invested capital −$239m in six months, NOPAT TTM +$382m; ROIC 38.4% |
| 3 | EMEA organic growth is negative, masked by consolidation; its output flows to the Americas | H1 organic −14.8%, gross sales +5.4%, intersegment +51.4% |
| 4 | One third of H1 EPS growth came from the tax line | effective rate 28.8% → 16.1%; restated growth +53.4%, not +80.8% |
| 5 | Two deep drawdowns in two years, neither about fundamentals; the leverage sits in options and passive flows | 2025H1 −61.3% (NVDA −36.9% same window); since May 2026 −29.2% (NVDA −2.7%) |
Key data (processed, not copied)
| Metric | Reading | Basis |
|---|---|---|
| Return on invested capital (TTM) | 38.4%, +36pp in four years | NOPAT ÷ average invested capital, full quarterly series charted |
| Deferred revenue (total) | $3.76bn, +95.4% in six months | customers fund the build-out; the substitute for the halted order metrics |
| Cash conversion cycle | 106.4 days — back at the 2022 crisis level | opposite structure: passive bleed then, deliberate build now; 27 quarters charted |
| Growth spread vs. weighted industry | FY2025 +10.0pp → 2026H1 +7.4pp | revenue-weighted peer set, computed; the alpha is narrowing |
| Funding flows | shorts 3.4%, flat skew, IV 18pp under realised vol | the market is not paying for gap protection |
Three horizons and the target
| Horizon | View |
|---|---|
| Monthly | Event window: options price ±13% into the print; protection stacked on the 18 Sep chain |
| Quarterly | Two Q3 checkpoints — deferred-revenue momentum and EMEA organic — decide whether the base case holds |
| Annual | Neutral / Hold, target $259: bear $144 (25%) / base $261 (50%) / bull $369 (25%), drawn as a price ladder with the market's implied position and the option ±1σ band; migration triggers set in advance |
Report structure (19 chapters + 4 appendices)
| Ch. | What the report delivers |
|---|---|
| 2 | The disclosure teardown end to end: the three-step timeline, management verbatim, three earnings-day reactions, the substitute dashboard |
| 7 | Where the capital comes from and what it returns: the invested-capital/NOPAT scissors; how much it spends to earn a dollar, and whose money it is |
| 9 | Ownership taken apart: event-date 13G holders, the private-equity and activist exits, 90 Form 4 filings trade by trade |
| 10 | Weighted industry growth and the peer mirror: the leader vs. chasers printing surging orders with breaking margins |
| 12 | Funding flows and leverage: two deleveragings quantified, three leverage layers each with a gauge |
| 15 | The operating framework: scenario-to-action map, entry and kill conditions, three expressions compared, risk budget |
| 19 | Settling the previous edition: four statements scored — one hit, three pending, one wording error corrected in the open |
What changed from the second edition
Rebuilt after a three-lane adversarial audit; all 18 revisions are published in Appendix C, three of which deserve the front page: ① v2 called the halt "almost absent from public discussion" — with transcripts in hand, management announced it live and analysts pressed it; the claim was wrong and Chapter 2 is rebuilt; ② v2's scenario EPS implied mutually inconsistent tax rates — re-derived on a single engine, the target moves from $268 to $259; ③ the 2025Q1 disclosure status was mislabelled and is corrected from the release text. This report publishes its own errors — one of the ways paid research separates itself from free content.
Sources and verifiability
Primary sources: SEC EDGAR (CIK 0001674101) — 10-K, 10-Q, twelve quarterly releases, DEF 14A, 13D/13G and 90 Form 4 filings — XBRL companyfacts (27 quarters), FINRA short interest, CBOE option chains, SSGA fund holdings; peers from Eaton, nVent and Modine filings plus Schneider and Munters interims. Every claim carries an [A]/[B]/[C]/[D] evidence grade; twelve known limits are listed; every computed figure (cash cycle, ROIC, weighted industry growth, reverse DCF, exit multiples, option band) is reproduced with formulas and intermediates in Appendix D.
How this report was produced, and disclaimer
Compiled independently by the TopX research team from public information, then reviewed and revised before release by professional investment managers and fund managers with asset-management experience. Reviewers take part in a personal capacity, do not represent their respective employers, and provide no investment advisory services through TopXEA; TopXEA holds no investment-adviser licence in any jurisdiction. Primary filings (SEC, exchanges, company disclosures) are the first-priority source, key figures require corroboration from at least two independent sources, claims carry [A]/[B]/[C]/[D] evidence grades, and known limitations are disclosed item by item inside the report. This is research content. It does not constitute investment advice and is not tailored to any particular investor; past data and forward projections do not indicate future results. Please note before purchase: digital goods are non-refundable once delivered.
Scorecard
Record period · 2026-08-21 – 2026-08-28Average time to resolution: 0.2 months
All registered calls, verification criteria and revisions are retained. Linked reports may have newer editions; read historical calls with their registration dates and revision notes.
Two base-case checkpoints: deferred revenue keeps growing q/q and faster than inventory; EMEA organic narrows from −2.4% or turns positive. Company guides Q3 organic +34–36%, above Q2's +18% — guidance itself raises the bar for a miss
- Verification / falsification criteria
Q3 release and 10-Q segment note
- Benchmark / verification source
Ch. 4, 6
- Subsequent evidence & revisions
No settlement evidence recorded yet.
Removing the quarterly order anchor systematically amplifies volatility on negative earnings days. On the next earnings day with a revenue miss, the stock's excess decline will be at least 5 percentage points. Reference: the −15.3 pp stock-specific component on July 29, 2026; flat option skew and implied volatility 18 pp below realized volatility suggest the market has not bought gap protection.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
At the next earnings release with a revenue miss, the stock's excess decline is less than 5 percentage points; or the company resumes quarterly order disclosures, removing the premise.
- Benchmark / verification source
QQQ on the same day
- Subsequent evidence & revisions
No settlement evidence recorded yet.
Growth no longer consumes shareholder capital: customer advances and supplier payment terms fund expansion. Invested capital fell $239 million from Q4 2025 to Q2 2026 while trailing-12-month NOPAT rose $382 million. Continued deferred-revenue growth above inventory growth is the accounting sign that this structure persists.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
Deferred revenue falls quarter over quarter for two consecutive quarters while inventory does not fall: the funding source disappears before demand, reversing the structure.
- Benchmark / verification source
None (structural judgment)
- Subsequent evidence & revisions
No settlement evidence recorded yet.
Neutral / Hold. The 12-month target is $259, probability-weighted across three scenarios of $144 / $261 / $369, or 2.8% below the August 27, 2026 close of $266.33. The base case assumes deferred revenue keeps growing faster than inventory, EMEA's contraction narrows, and the multiple converges from 39.8× to 31×.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
The stock's 12-month absolute return leaves the −10% to +5% Neutral band without the corresponding transition conditions triggering a rating change under the rules: Buy below $210, or FY27 growth guidance of at least +26% together with annual-report orders of at least +40%; Sell on a reversal of the inventory/deferred-revenue pattern, two consecutive quarters missing guidance, or share sales by the CEO or CFO.
- Benchmark / verification source
S&P 500
- Subsequent evidence & revisions
No settlement evidence recorded yet.
Event window, direction neutral. Options price ±13.0% (±1σ) to the 18 Sep expiry; the late-October Q3 print is the next gap risk; the Sep chain holds 55k puts vs. 30k calls — protection concentrates ahead of the print
- Verification / falsification criteria
did realised movement stay inside $232–$301
- Benchmark / verification source
option chain [B], earnings calendar
- Subsequent evidence & revisions
No settlement evidence recorded yet.
EMEA's organic contraction is regional, not global: organic growth was −14.8% in EMEA in first-half 2026, versus +31.0% in the Americas and +19.6% in Asia-Pacific. EMEA's operating margin also rose from 20.8% to 22.1%.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
A quarter with organic growth below +10% in either the Asia-Pacific or Americas segment makes this conclusion incorrect.
- Benchmark / verification source
S&P 500
- Subsequent evidence & revisions
No settlement evidence recorded yet.
The interruption in order disclosures is an information event, not an operating-performance event. It followed, rather than preceded, record quarterly organic order growth of +252%. Revenue, gross margin and cash flow did not deteriorate, and the company raised full-year guidance at the same time.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
Revenue below guidance in Q3 or Q4 2026, or a quarter-over-quarter gross-margin decline greater than 150 basis points, would show that the disclosure interruption masked deterioration already under way rather than a reporting-basis adjustment, making this conclusion incorrect.
- Benchmark / verification source
S&P 500
- Subsequent evidence & revisions
The third-edition investigation confirmed a disclosure-policy change publicly announced by management on the February 11, 2026 earnings call. The CEO cited excessive quarterly volatility. Shares rose 24.5% that day. Revenue, cash flow and guidance strengthened around the change: deferred revenue rose 95.4% in six months and guidance was raised twice. The information-event rather than performance-event assessment holds. Sources: call transcript [B] and 8-K / 10-Q [A]; see v3, Chapter 2.
The constraint is supply, not demand. The company says orders exceed its delivery capacity. Inventory days rose from 74 to 113, and first-half 2026 capex of $285.9 million already exceeded full-year 2025 capex of $220 million.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
A quarter in which inventory days rise while contract liabilities fall quarter over quarter reverses the pattern from insufficient capacity to insufficient demand and makes this conclusion incorrect.
- Benchmark / verification source
S&P 500
- Subsequent evidence & revisions
No settlement evidence recorded yet.
Neutral / Hold. The probability-weighted 12-month target of $268 is 2.3% above the August 21, 2026 close of $261.95. The base case has a 50% weight and FY2027 adjusted diluted EPS of $8.70 × 31× = $270.
12-month horizonLinked report: Vertiv (VRT) Deep Research — Bilingual Edition- Verification / falsification criteria
Either a stock price below $215, corresponding to 25 times forward earnings in the base case, or disclosed FY2027 revenue-growth guidance above +30% makes this conclusion incorrect.
- Benchmark / verification source
S&P 500
- Subsequent evidence & revisions
Superseded by the third edition before the 12-month window ended. An audit found mutually inconsistent tax rates implied by the three scenario EPS figures (revision #17). Recalculation with a unified engine moved the target from $268 to $259; the Neutral rating remained. Tracking continues over the original window under the new target in a newly registered entry.
Method: every call registered in the period is shown — nothing is selected out. Hit rate = hits ÷ (hits + misses); open calls are excluded from the denominator. Outcomes are judged against the falsification conditions stated in each report. Monthly and quarterly outlooks are settled on the events named in each report's table; they were added to the ledger on 2026-10-13 and carry the report's publication date. Past performance does not indicate future results. Not investment advice.
Your download link is issued automatically after payment (both the English and Chinese PDFs ship in one package) and can be re-downloaded any time from My Account → My Reports.
Reports are delivered as PDFs; the download link is non-refundable once issued — every report ships with free sample pages, so read the sample first. This is research content. It does not constitute investment advice, an offer or a solicitation, and is not tailored to any particular investor's financial situation, objectives or risk tolerance; ratings and target prices are analytical judgments about relative performance, not instructions to buy or sell. Past data and forward projections do not indicate future results.
Further reading
After Orders Grew 252%, Vertiv Stopped Disclosing Orders
For ten consecutive quarters Vertiv disclosed order growth, book-to-bill and backlog every quarter. In Q4 2025 those read +252%, 2.9x and $15.0bn — and on the same call management announced they would no longer be reported quarterly; both releases since count zero. Includes the reproducible method, and the trap that produces the opposite conclusion if you skip it.
Vertiv Insiders Sold $142M in Twelve Months. $41M of It Was Not a Reduction.
We parsed all 90 of Vertiv's (NYSE: VRT) Forms 4 over twelve months, 150 transactions, one at a time. Strip out cashless exercises and net accumulators and the usable figure is $100.8m — of which 91.9% came from the board, while the CEO and CFO sold nothing. Reproducible steps included.
What Actually Changes an MT5 Backtest — We Ran the Controlled Test
Same EA, same .set, two different equity curves. We isolated the chart timeframe in a controlled test: 60× the bar count, and every figure in both reports came back identical. The variables that actually move the number are elsewhere — ranked by impact, with our own measured data.
Comfort Systems: What Sustained Project Margins Are Worth
A source-backed FIX deep dive: data-center demand, project margins, working capital and the growth required by valuation. Includes a reproducible model.
More products
Riot Platforms (RIOT) Deep Research — Bilingual Edition
1st edition · EN + ZH PDFs · 26 figures, 109 tables · three-horizon view · Target-price analysis
Read 8 pages free
FormFactor (FORM) Deep Research — Bilingual Edition
1st edition · EN + ZH PDFs · 33 figures, 128 tables · three-horizon view · Target-price analysis
Read 8 pages free
Applied Optoelectronics (AAOI) Deep Research — Bilingual Edition
1st edition · EN + ZH PDFs · 40 figures, 151 tables · three-horizon view · Target-price analysis
Read 8 pages free
IREN (IREN) Deep Research — Bilingual Edition
1st edition · EN + ZH PDFs · 12 figures, 60 tables · three-horizon view · Target-price analysis
Read 8 pages free
TeraWulf (WULF) Deep Research — Bilingual Edition
1st edition · EN + ZH PDFs · 12 figures, 56 tables · three-horizon view · Target-price analysis
Read 8 pages free
Palantir (PLTR) Deep Dive · 2nd Edition
2nd edition · EN+ZH PDFs · 14 figures, 17 tables · three horizons · Accumulate, $201
Read 8 pages free